|
Apr 4
|
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
|
|
Mar 27
|
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Jan 12
|
Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?
|
|
Jan 9
|
RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average
|
|
Jan 7
|
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
|
|
Nov 15
|
RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average
|
|
Sep 7
|
RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors
|
|
Aug 8
|
RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript
|
|
Aug 8
|
Q2 2023 Rxsight Inc Earnings Call
|
|
Aug 7
|
RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
RxSight, Inc. Reports Second Quarter 2023 Financial Results
|